Betahistine 24 mg bid (Betaserc)

DRUG2 trials

Sponsors

Solvay Pharmaceuticals, Sisli Hamidiye Etfal Training and Research Hospital

Conditions

Meniere's DiseaseNeural Therapy of HunekeTinnitus

Phase 4

Effects of Betaserc on Vestibular Compensation in Patients Suffering From Disabling Meniere's Disease and Having Undergone Vestibular Neurotomy

CompletedNCT00160238

Solvay PharmaceuticalsMeniere's Disease

Start: 2003-01-31Target: 20Updated: 2006-12-22

Unknown Phase

The Effects of Conventional Therapy on Tinnitus, Disability, and Quality of Life in Patients With Tinnitus

Not yet recruitingNCT07334002

Sisli Hamidiye Etfal Training and Research HospitalNeural Therapy of Huneke, Tinnitus

Start: 2026-03-01End: 2026-05-26Target: 30Updated: 2026-03-23